Concurrent management of multiple sclerosis and natalizumab-induced hepatitis with ofatumumab: a case report

MeSH terms

• Adult
• Antibodies, Monoclonal, Humanized* / adverse effects
• Antibodies, Monoclonal, Humanized* / therapeutic use
• Chemical and Drug Induced Liver Injury* / etiology
• Female
• Humans
• Immunologic Factors* / adverse effects
• Multiple Sclerosis / drug therapy
• Multiple Sclerosis, Relapsing-Remitting / drug therapy
• Natalizumab* / adverse effects
• Natalizumab* / therapeutic use